Roles of BCL-2 and caspase 3 in the adenosine A3 receptor-induced apoptosis

被引:33
作者
Appel, E
Kazimirsky, G
Ashkenazi, E
Kim, SG
Jacobson, KA
Brodie, C [1 ]
机构
[1] Bar Ilan Univ, Fac Life Sci, Gonda Goldschmied Med Diag Res Ctr, IL-52900 Ramat Gan, Israel
[2] Hadassa Hosp, Dept Neurosurg, Jerusalem, Israel
[3] NIDDKD, Bioorgan Chem Lab, Mol Recognit Sect, NIH, Bethesda, MD 20892 USA
关键词
astrocytes; agonists; adenosine receptor; apoptosis; Bcl-2;
D O I
10.1385/JMN:17:3:285
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Selective A(3) adenosine receptor agonists have been shown to induce apoptosis in a variety of cell types. In this study we examined the effects of adenosine receptor agonists selective for A(1), A(2)A, or A(3) receptors on the induction of apoptosis in primary cultures of rat astrocytes and in C6 glial cells. Treatment of the cells with the A(3) receptor agonist CI-IB-MECA (10 muM) induced apoptosis in both cell types. The effects of CI-IB-MECA were partially antagonized by the A(3) receptor-selective antagonist MRS 1191. In contrast, the A(1) and A(2A) receptor agonists, CPA and CGS 21680, respectively, did not have significant effects on apoptosis in these cells. CI-IB-MECA reduced the expression of endogenous Bcl-2, whereas it did not affect the expression of Bax. Overexpression of Bcl-2 in C6 cells abrogated the induction of apoptosis induced by the A(3) agonist. CI-IB-MECA also induced an increase in caspase 3 activity and caspase inhibitors decreased the apoptosis induced by the A(3) agonist. These findings suggest that intense activation of the A(3) receptor is pro-apoptotic in glial cells via bcl2 and caspase-3 dependent pathways.
引用
收藏
页码:285 / 292
页数:8
相关论文
共 23 条
  • [1] The A3 adenosine receptor mediates cell spreading, reorganization of actin cytoskeleton, and distribution of Bcl-xL:: Studies in human astroglioma cells
    Abbracchio, MP
    Rainaldi, G
    Giammarioli, AM
    Ceruti, S
    Brambilla, R
    Cattabeni, F
    Barbieri, D
    Franceschi, C
    Jacobson, KA
    Malorni, W
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 241 (02) : 297 - 304
  • [2] Brodie C, 1997, GLIA, V19, P275
  • [3] Protein kinase C δ (PKCδ) inhibits the expression of glutamine synthetase in glial cells via the PKCδ regulatory domain and its tyrosine phosphorylation
    Brodie, C
    Bogi, K
    Acs, P
    Lorenzo, PS
    Baskin, L
    Blumberg, PM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (46) : 30713 - 30718
  • [4] Activation of the A2A adenosine receptor inhibits nitric oxide production in glial cells
    Brodie, C
    Blumberg, PM
    Jacobson, KA
    [J]. FEBS LETTERS, 1998, 429 (02): : 139 - 142
  • [5] CERUTI S, 1996, DRUG DEVELOP RES, V3, P177
  • [6] Dunwiddie TV, 1997, J NEUROSCI, V17, P607
  • [7] FREDHOLM BB, 1994, PHARMACOL REV, V46, P143
  • [8] A ROLE FOR CENTRAL A(3)-ADENOSINE RECEPTORS - MEDIATION OF BEHAVIORAL DEPRESSANT EFFECTS
    JACOBSON, KA
    NIKODIJEVIC, O
    SHI, D
    GALLORODRIGUEZ, C
    OLAH, ME
    STILES, GL
    DALY, JW
    [J]. FEBS LETTERS, 1993, 336 (01) : 57 - 60
  • [9] Pharmacological characterization of novel A(3) adenosine receptor-selective antagonists
    Jacobson, KA
    Park, KS
    Jiang, JL
    Kim, YC
    Olah, ME
    Stiles, GL
    Ji, XD
    [J]. NEUROPHARMACOLOGY, 1997, 36 (09) : 1157 - 1165
  • [10] 2-SUBSTITUTION OF N-6-BENZYLADENOSINE-5'-URONAMIDES ENHANCES SELECTIVITY FOR A-3 ADENOSINE RECEPTORS
    KIM, HO
    JI, XD
    SIDDIQI, SM
    OLAH, ME
    STILES, GL
    JACOBSON, KA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (21) : 3614 - 3621